Change in Director's Duties

By

Regulatory News | 16 Oct, 2024

Updated : 12:00

RNS Number : 3114I
Treatt PLC
16 October 2024
 

 

 

16 October 2024

 

 

TREATT PLC

("Treatt" or "the Company")

 

Change in Director's Duties

 

Treatt, the manufacturer and supplier of a diverse and sustainable portfolio of natural extracts and ingredients for the beverage, flavour and fragrance industries, announces that, Ryan Govender, Chief Financial Officer, will add to his existing responsibilities in a new operational role as Managing Director for Europe to focus on driving regional growth.

 

David Shannon, Chief Executive Officer, commented 'As part of our strategic growth plans to expand our reach, Treatt will be operated as a globally led, regionally delivered organisation. As part of this additional role Ryan will be responsible for leading the European leadership team.  Ryan's extensive knowledge of the business and entrepreneurial approach will enable us to drive the business as a regionally delivered organisation.  Ryan will continue his role as CFO, well supported by the Group's strong finance function.'

 

The Company confirms there are no further disclosures to be made under UKLR 6.4.6 of the Listing Rules.

 

 

 

 

 

 

 

 

 

For further information please contact:

 

Treatt plc                                                                                                            

Abby Burton-Hopkins

Assistant Company Secretary

 

01284 702500

 

END

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
BOAGPGBWUUPCGQA

Last news